Gorilla's FY2025 Revenue Growth Masks Persistent Cash Conversion Risks

What happened

Gorilla Technology reported a 35.7% increase in FY2025 revenue to $101.4 million, alongside a 91.7% improvement in EPS and a 79.6% reduction in operating loss, highlighting top-line execution and cost discipline. However, the positive headline figures obscure underlying cash flow challenges, as the company's operating cash flow remained negative in the first nine months of 2025, with $15.1 million used. Currency exchange losses, primarily from Egyptian pound depreciation, amounted to $15.0 million over the same period, indicating persistent FX risks from firm-fixed price contracts. Customer concentration remains extreme, with Taiwan accounting for approximately 99% of 2024 revenue, amplifying vulnerability to payment delays or scope changes. The key investment thesis hinges on converting backlog into cash, and while revenue growth is promising, the lack of full-year cash flow data leaves the conversion risk unaddressed.

Implication

The revenue growth confirms Gorilla's ability to secure and execute large contracts, but cash conversion from milestone billing remains a critical hurdle. Negative operating cash flow and significant FX losses highlight ongoing liquidity and earnings quality issues that could pressure future financing needs. High customer concentration in Taiwan and Egypt increases operational risk, making the business susceptible to single-client disruptions. Upcoming catalysts, such as FY2025 full cash flow disclosure and Freyr Phase 1 commissioning updates, will be essential to validate the 2026 revenue guidance. Without evidence of improved collections and reduced FX headwinds, the stock's valuation at $11.35 may not be justified, supporting a continued wait-and-see approach.

Thesis delta

The new FY2025 results do not significantly alter the investment thesis, as they reinforce revenue growth but fail to address core cash conversion concerns. The thesis remains dependent on observable improvements in operating cash flow and milestone execution over the next 3-6 months, with no shift from the WAIT rating.